共 50 条
- [42] Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (02): : 168 - 177
- [43] Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19 JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (24):
- [45] Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19 FRONTIERS IN IMMUNOLOGY, 2021, 12
- [46] The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 Infection PATHOGENS, 2021, 10 (03):
- [47] COVID-19 and angiotensin-converting enzyme inhibitors from plant origin JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2022, 20 (05):
- [50] COVID-19 and the use of angiotensin-converting enzyme inhibitors and receptor blockers. Scientific brief PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2020, 16 (01): : 120 - 121